Search

everythinglearnresearchcommunity

for

Search:↓

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

Women with PCOS have distinct retinal changes compared to healthy women.

Early diagnosis and management of Sheehan's syndrome are crucial for improving quality of life and fertility.

Androgenetic alopecia may improve meibum quality in eyes.

Agoutis in captivity have more resting (telogen) hairs than growing (anagen) hairs, regardless of season or gender.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

New methods may speed up drug development for male subfertility.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Accurate diagnosis is crucial to distinguish between PCOS and rare ovarian tumors in teens with similar symptoms.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.